Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
American Journal of Clinical Dermatology
Erschienen in: American Journal of Clinical Dermatology 4/2009

01.08.2009 | Review Article

Acute Urticaria and Angioedema

Diagnostic and Treatment Considerations

verfasst von: Dr Evangelo Frigas, Miguel A. Park

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Urticaria is defined as wheals consisting of three features: (i) central swelling of various sizes, with or without surrounding erythema; (ii) pruritus or occasional burning sensations; and (iii) the skin returning to normal appearance, usually within 1–24 hours. Angioedema is defined as: (i) abrupt swelling of the lower dermis and subcutis; (ii) occasional pain instead of pruritus; (iii) commonly involving the mucous membranes; and (iv) skin returning to normal appearance, usually within 72 hours. Acute urticaria and angioedema is defined by its duration (<6 weeks) comparedwith chronic urticaria and angioedema. The most common causes are infections, medications, and foods. The best tools in the evaluation of these patients are a comprehensive history and physical examination. There are a variety of skin conditions that may mimic acute urticaria and angioedema and the various reaction patterns associated with different drugs. Oral antihistamines are first-line treatment. In the event of a life-threatening reaction involving urticaria with angioedema, epinephrine may be needed to stabilize the patient. This review focuses on the value of a comprehensive clinical evaluation at the onset of symptoms. It underscores the importance of coordination of care among physicians, and the development of an action plan for evidence-based investigations, diagnosis, and therapy.
Literatur
1.
Kaplan A. Urticaria and angioedema. In: Adkinson NFYJ, Busse WW, Bochner BS, et al., editors. Middleton’s allergy principles and practice. 6th ed. Philadelphia (PA): Mosby, 2003: 1537–58
2.
3.
Champion RH, Roberts SO, Carpenter RG, et al. Urticaria and angiooedema: a review of 554 patients. Br J Dermatol 1969; 81 (8): 588–97PubMedCrossRef
4.
Gaig P, Olona M, Munoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004; 14 (3): 214–20PubMed
5.
Bigby M, Jick S, Jick H, et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256 (24): 3358–63PubMedCrossRef
6.
Grattan CE, Humphreys F, British Association of Dermatologists Therapy guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157 (6): 1116–23
7.
Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006; 61 (3): 316–20PubMedCrossRef
8.
Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, et al. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 1998; 134 (3): 319–23PubMedCrossRef
9.
Volcheck G. Clinical allergy diagnosis and management. 1st ed. New York: Springer, 2009: 279–309
10.
Council for International Organization of Medical Sciences. Harmonizing use of adverse drug reaction terms: definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders. Pharmacoepidemiol Drug Saf 1997; 6: 115–27
11.
Litt J. Drug eruption reference manual. 14th ed. New York: Informa Healthcare, 2008: 1–657
12.
Zuberbier T, Greaves MW, Juhlin L, et al. Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001; 6 (2): 123–7PubMedCrossRef
13.
Shin HT, Chang MW. Drug eruptions in children. Curr Probl Pediatr 2001; 31 (7): 207–34PubMed
14.
Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21 (3): 247–54PubMed
15.
Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. JAMA 1979; 242 (7): 623–32PubMedCrossRef
16.
Hutchinson TA, Leventhal JM, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: II. Demonstration of reproducibility and validity. JAMA 1979; 242 (7): 633–8PubMedCrossRef
17.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (2): 239–45PubMedCrossRef
18.
Assem E. Drug allergy and tests for its detection. 5th ed. London: Chapman and Hall Medical, 1998: 791–815
19.
Anonymous. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999; 83 (6 Pt 3): 665–700
20.
Frigas E, Park MA, Narr BJ, et al. Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice. Mayo Clinic Proc 2008; 83 (6): 651–62
21.
Kalogeromitros D, Rigopoulos D, Gregoriou S, et al. Penicillin hypersensitivity: value of clinical history and skin testing in daily practice. Allergy Asthma Proc 2004; 25 (3): 157–60PubMed
22.
Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 2003; 111 (5): 1111–5PubMedCrossRef
23.
Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr 1998; 132 (1): 137–43PubMedCrossRef
24.
Sogn DD, Evans III R, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major andminor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152 (5): 1025–32PubMedCrossRef
25.
Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69 (2): 238–44PubMedCrossRef
26.
Aoki T, Kojima M, Horiko T. Acute urticaria: history and natural course of 50 cases. J Dermatol 1994; 21 (2): 73–7PubMed
27.
Legrain V, Taieb A, Sage T, et al. Urticaria in infants: a study of forty patients. Pediatr Dermatol 1990; 7 (2): 101–7PubMedCrossRef
28.
Sampson HA. Adverse reactions to foods. In: Adkinson DFYJ, Busse WW, Bochner BS, et al., editors. Middleton’s allergy principles and practice. 6th ed. Philadelphia (PA): Mosby, 2003: 1619–43
29.
Pfrommer C, Bastl R, Vieths S, et al. Characterization of naturally occurring pseudoallergens causing chronic urticaria [abstract]. J Allergy Clin Immunol 1996; 97: 367CrossRef
30.
31.
Giehtbrock K, Flynn S, Andrist D, et al. Oral provocation testing with common dyes and preservatives used by the food industry: our experience over the last five years [abstract]. J Allergy Clin Immunol 1999; 103 (1 Pt 2): S6
32.
Kozel MM, Mekkes JR, Bossuyt PM, et al. The effectiveness of a historybased diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134 (12): 1575–80PubMedCrossRef
33.
Henderson Jr RL, Fleischer Jr AB, Feldman SR. Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists. J Am Acad Dermatol 2000; 43 (6): 1084–91PubMedCrossRef
34.
Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter. Part I: acute urticaria/angioedema. Part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000; 85 (6 Pt 2): 521–44
35.
Kauppinen K, Juntunen K, Lanki H. Urticaria in children: retrospective evaluation and follow-up. Allergy 1984; 39 (6): 469–72PubMedCrossRef
36.
Grunewald SM, Hahn C, Wohlleben G, et al. Infection with influenza A virus leads to flu antigen-induced cutaneous anaphylaxis in mice. J Investig Dermatol 2002; 118 (4): 645–51PubMedCrossRef
37.
Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003; 111 (5): 1095–8PubMedCrossRef
38.
Molinaro G, Cugno M, Perez M, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine (9)-bradykinin. J Pharmacol Exp Ther 2002; 303 (1): 232–7PubMedCrossRef
39.
40.
Cicardi M, Zingale LC, Bergamaschini L, et al. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004; 164 (8): 910–3PubMedCrossRef
41.
Borazan A, Ustun H, Yilmaz A. Angioedema induced by angiotensin II blocker telmisartan [letter]. Allergy 2003; 58 (5): 454PubMedCrossRef
42.
Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9 (2): 71–9PubMedCrossRef
43.
Preston SL, Briceland LL, Lesar TS. Accuracy of penicillin allergy reporting. Am J Hosp Pharm 1994; 51 (1): 79–84PubMed
44.
Puchner Jr TC, Zacharisen MC. A survey of antibiotic prescribing and knowledge of penicillin allergy. Ann Allergy Asthma Immunol 2002; 88 (1): 24–9PubMedCrossRef
45.
Gadde J, Spence M, Wheeler B, et al. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270 (20): 2456–63PubMedCrossRef
46.
Simons F. Urticaria: principles of antihistamine treatment. New York: Marcel Dekker Inc., 2004
47.
Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. Br J Dermatol 1998; 138 (4): 635–8PubMedCrossRef
48.
Lippert U, Kruger-Krasagakes S, Moller A, et al. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxyloratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995; 4 (4 Pt 2): 272–6PubMedCrossRef
49.
Lippert U, Moller A, Welker P, et al. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists [published erratum appears in Exp Dermatol 2002 Aug; 11 (4): 386]. Exp Dermatol 2000; 9 (2): 118–24PubMedCrossRef
50.
Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004; 64 (22): 2515–36PubMedCrossRef
51.
Zuberbier T, Ifflander J, Semmler C, et al. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Dermato-Venereologica 1996; 76 (4): 295–7PubMed
52.
Berkun Y, Shalit M. Successful treatment of delayed pressure urticaria with montelukast. Allergy 2000; 55 (2): 203–4PubMedCrossRef
53.
Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998; 102 (5): 876–7PubMedCrossRef
54.
Greaves M, Lawlor F. Angioedema: manifestations and management. J Am Acad Dermatol 1991; 25 (1 Pt 2): 155–61; discussion 61-5PubMedCrossRef
55.
Cugno M, Nussberger J, Cicardi M, et al. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003; 3 (3): 311–7PubMedCrossRef
56.
57.
Frigas E, Nzeako UC. Angioedema: pathogenesis differential diagnosis, and treatment. Clin Rev Allergy Immunol 2002; 23 (2): 217–31PubMedCrossRef
58.
Lin RY, Cannon AG, Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol 2005; 95 (2): 159–66PubMedCrossRef
59.
Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol 2008; 101 (2): 185–92PubMedCrossRef
60.
Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006; 9 (175): 1065–70
61.
Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24 (8): 599–606PubMedCrossRef
62.
Ducroix JP, Outurquin S, Benabes-Jezraoui B, et al. Angio-oedemes et inhibiteurs de l’enzyme de conversion de l’angiotensine: a propos de 19 cas. Revue de Medecine Interne 2004; 25 (7): 501–6PubMedCrossRef
63.
Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 1997; 278 (3): 232–3PubMedCrossRef
64.
Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 1997; 23 (7): 793–6PubMedCrossRef
65.
Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 1993; 11 (4): 350–4PubMedCrossRef
66.
Ohnishi-Inoue Y, Mitsuya K, Horio T. Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist. Br J Dermatol 1998; 138 (3): 483–5PubMedCrossRef
67.
Sabroe RA, Black AK. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 1997; 136 (2): 153–8PubMedCrossRef
68.
Boxer M. Accupril- and cozaar-induced angioedema in the same patient [letter]. J Allergy Clin Immunol 1996; 98 (2): 471PubMedCrossRef
69.
70.
Frye CB, Pettigrew TJ. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy 1998; 18 (4): 866–8PubMed
71.
72.
Rupprecht R, Vente C, Grafe A, et al. Angioedema due to losartan. Allergy 1999; 54 (1): 81–2PubMedCrossRef
73.
Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997; 90 (5): 552–3PubMedCrossRef
74.
van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med 1998; 158 (18): 2063–5PubMedCrossRef
75.
Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992; 71 (4): 206–15PubMedCrossRef
76.
Cooney C, Nagy A. Angio-oedema associated with risperidone [letter]. BMJ 1995; 311 (7014): 1204PubMedCrossRef
77.
Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1999; 60 (10): 714–25; quiz 26PubMedCrossRef
78.
Mithani H, Hurwitz TA. Paroxetine-induced angioedema and tongue swelling [letter]. J Clin Psychiatry 1996; 57 (10): 486PubMedCrossRef
79.
Cooper JP, Quarry DP, Beale DJ, et al. Life-threatening, localized angiooedema associated with streptokinase. Postgrad Med J 1994; 70 (826): 592–3PubMedCrossRef
80.
Francis CW, Brenner B, Leddy JP, et al. Angioedema during therapy with recombinant tissue plasminogen activator. Br J Haematol 1991; 77 (4): 562–3PubMed
81.
Hill MD, Barber PA, Takahashi J, et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000; 162 (9): 1281–4PubMed
82.
Pancioli A, Brott T, Donaldson V, et al. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. Ann Emerg Med 1997; 30 (2): 227–9PubMedCrossRef
83.
Walls RM, Pollack Jr CV. Successful cricothyrotomy after thrombolytic therapy for acute myocardial infarction: a report of two cases. Ann Emerg Med 2000; 35 (2): 188–91PubMedCrossRef
84.
Temino VM, Peebles Jr RS. The spectrum and treatment of angioedema. Am J Med 2008; 121 (4): 282–6PubMedCrossRef
85.
Bork K, Barnstedt SE, Koch P, et al. Hereditary angioedema with normal C1 INH activity in women. Lancet 2000; 356 (9225): 213–7PubMedCrossRef
86.
Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001; 161 (5): 714–8PubMedCrossRef
87.
Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: consensus document [published erratum appears in Clin Exp Immunol 2005 Jul; 141 (1): 189-90]. Clin Exp Immunol 2005; 139 (3): 379–94PubMedCrossRef
88.
Gompels MM, Lock RJ, Morgan JE, et al. A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 2002; 55 (2): 145–7PubMedCrossRef
89.
Caldwell JR, Ruddy S, Austen KF. Assay of complement components C1,C4, C2, C3 and C9 in whole rat serum. Int Arch Allergy Appl Immunol 1972; 43 (6): 887–97PubMedCrossRef
90.
Cohen SH, Koethe SM, Kozin F, et al. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy: acquired angioedema treated with danazol. J Allergy Clin Immunol 1978; 62 (4): 217–21PubMedCrossRef
91.
Donaldson VH, Hess EV, McAdams AJ. Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema. Ann Intern Med 1977; 86 (3): 312–3PubMed
92.
Hauptmann G, Lang JM, North ML, et al. Acquired C1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities: a study of three cases. Blut 1976; 32 (3): 195–206PubMedCrossRef
93.
Schreiber AD, Zweiman B, Atkins P, et al. Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood 1976; 48 (4): 567–80PubMed
94.
Anonymous. The diagnosis and management of anaphylaxis. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology [published erratum appears in J Allergy Clin Immunol 1998 Aug; 102 (2): 264]. J Allergy Clin Immunol 1998; 101 (6 Pt 2): S465–528
95.
Lock RJ, Gompels MM. C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies? Curr Allergy Asthma Rep 2007; 7 (4): 264–9PubMedCrossRef
96.
Frank MM. Hereditary angioedema: a half century of progress. J Allergy Clin Immunol 2004; 114 (3): 626–8PubMedCrossRef
97.
Trachsel D, Hammer J. A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema. Intensive Care Med 1999; 25 (11): 1335–6PubMedCrossRef
98.
Pekdemir M, Ersel M, Aksay E, et al. Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med 2007; 33 (2): 137–9PubMedCrossRef
99.
Prematta M, Gibbs JG, Pratt EL, et al. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 2007; 98 (4): 383–8PubMedCrossRef
100.
Longhurst HJ. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 2005; 59 (5): 594–9PubMedCrossRef
101.
Friedmann PS. Assessment of urticaria and angio-oedema. Clin Exp Allergy 1999; 29 Suppl. 3: 109–12; discussion 13-5PubMedCrossRef
102.
Bernstein JA. Hereditary angioedema: a current state-of-the-art review: VIII. Current status of emerging therapies. Ann Allergy Asthma Immunol 2008; 100 (1 Suppl. 2): S41–6
103.
Bork K, Hardt J, Schicketanz KH, et al. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003; 163 (10): 1229–35PubMedCrossRef
104.
Bork K, Koch P. Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. J Am Acad Dermatol 2001; 45 (6): 968–9PubMedCrossRef
105.
Bork K, Meng G, Staubach P, et al. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005; 45 (11): 1774–84PubMedCrossRef
106.
Farkas H, Harmat G, Fust G, et al. Clinical management of hereditary angiooedema in children. Pediatr Allergy Immunol 2002; 13 (3): 153–61PubMedCrossRef
107.
Zuraw BL. Current and future therapy for hereditary angioedema. Clin Immunol 2005; 114 (1): 10–6PubMedCrossRef
108.
Choi G, Soeters MR, Farkas H, et al. Recombinant human C1-inhibitor in the treatment of acute angioedema attacks. Transfusion 2007; 47 (6): 1028–32PubMedCrossRef
109.
Longhurst H. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. Curr Opin Investig Drugs 2008; 9 (3): 310–23PubMed
110.
Levy JH, O’Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Exp Opin Investig Drugs 2006; 15 (9): 1077–90CrossRef
111.
Waton J, Boulanger A, Trechot PH, et al. Contact urticaria from Emla cream. Contact Derm 2004; 51 (5-6): 284–7PubMedCrossRef
112.
Krautheim AB, Jermann TH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Derm 2004; 50 (3): 113–6PubMedCrossRef
113.
Andrews AW, Fornwald JA, Lijinsky W. Nitrosation and mutagenicity of some amine drugs. Toxicol Appl Pharmacol 1980; 52 (2): 237–44PubMedCrossRef
Metadaten
Titel
Acute Urticaria and Angioedema
Diagnostic and Treatment Considerations
verfasst von
Dr Evangelo Frigas
Miguel A. Park
Publikationsdatum
01.08.2009
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 4/2009
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200910040-00004

Weitere Artikel der Ausgabe 4/2009

American Journal of Clinical Dermatology 4/2009 Zur Ausgabe

Case Reports

Basal Cell Carcinoma Presenting Late in a Shotgun Scar

Review Article

Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis

BookReview

Book Reviews

Case Reports

Vitiligo Koebnerized by Behçet Disease Genital Ulceration

Case Reports

Focal Acral Hyperpigmentation in a Patient Undergoing Chemotherapy with Capecitabine

Therapy in Practice

Toenail Onychomycosis in Diabetic Patients

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise